AU770157B2 - Use of semaphorin for modulation of cellular efflux - Google Patents
Use of semaphorin for modulation of cellular efflux Download PDFInfo
- Publication number
- AU770157B2 AU770157B2 AU73556/00A AU7355600A AU770157B2 AU 770157 B2 AU770157 B2 AU 770157B2 AU 73556/00 A AU73556/00 A AU 73556/00A AU 7355600 A AU7355600 A AU 7355600A AU 770157 B2 AU770157 B2 AU 770157B2
- Authority
- AU
- Australia
- Prior art keywords
- leu
- ser
- lys
- thr
- val
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15291499P | 1999-09-08 | 1999-09-08 | |
US60/152914 | 1999-09-08 | ||
US15625799P | 1999-09-27 | 1999-09-27 | |
US60/156257 | 1999-09-27 | ||
US17390699P | 1999-12-29 | 1999-12-29 | |
US60/173906 | 1999-12-29 | ||
PCT/US2000/024560 WO2001018044A2 (fr) | 1999-09-08 | 2000-09-07 | Modulation par semaphorines de l'efflux cellulaire |
Publications (2)
Publication Number | Publication Date |
---|---|
AU7355600A AU7355600A (en) | 2001-04-10 |
AU770157B2 true AU770157B2 (en) | 2004-02-12 |
Family
ID=27387351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU73556/00A Ceased AU770157B2 (en) | 1999-09-08 | 2000-09-07 | Use of semaphorin for modulation of cellular efflux |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1210368A2 (fr) |
AU (1) | AU770157B2 (fr) |
CA (1) | CA2384104A1 (fr) |
WO (1) | WO2001018044A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1307557A2 (fr) | 2000-08-02 | 2003-05-07 | The Johns Hopkins University | Profils d'expression de cellules endotheliales |
EP1429801A1 (fr) * | 2001-09-26 | 2004-06-23 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Neuropiline comme nouvelle cible therapeutique pour la modulation de reponses immunitaires |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995007701A1 (fr) * | 1993-09-17 | 1995-03-23 | Romano Deghenghi | Compositions pharmaceutiques orales, solubles dans l'eau, a base de derives d'oestrone et de sel de calcium |
WO1999021997A1 (fr) * | 1997-10-28 | 1999-05-06 | Immunex Corporation | Adn et polypeptides recepteurs des proteines de semaphorine a codage viral |
AU2982799A (en) * | 1998-03-03 | 1999-09-20 | Zymogenetics Inc. | Human semaphorin zsmf-7 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5639856A (en) * | 1993-09-13 | 1997-06-17 | The Regents Of The University Of California | Semaphorin gene family |
-
2000
- 2000-09-07 EP EP00961634A patent/EP1210368A2/fr not_active Withdrawn
- 2000-09-07 WO PCT/US2000/024560 patent/WO2001018044A2/fr not_active Application Discontinuation
- 2000-09-07 CA CA002384104A patent/CA2384104A1/fr not_active Abandoned
- 2000-09-07 AU AU73556/00A patent/AU770157B2/en not_active Ceased
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995007701A1 (fr) * | 1993-09-17 | 1995-03-23 | Romano Deghenghi | Compositions pharmaceutiques orales, solubles dans l'eau, a base de derives d'oestrone et de sel de calcium |
WO1999021997A1 (fr) * | 1997-10-28 | 1999-05-06 | Immunex Corporation | Adn et polypeptides recepteurs des proteines de semaphorine a codage viral |
AU2982799A (en) * | 1998-03-03 | 1999-09-20 | Zymogenetics Inc. | Human semaphorin zsmf-7 |
Also Published As
Publication number | Publication date |
---|---|
WO2001018044A3 (fr) | 2001-10-25 |
CA2384104A1 (fr) | 2001-03-15 |
WO2001018044A2 (fr) | 2001-03-15 |
EP1210368A2 (fr) | 2002-06-05 |
AU7355600A (en) | 2001-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8211864B2 (en) | Compositions and methods for the intracellular disruption of VEGF and VEGFR-2 by intraceptors | |
AU745235B2 (en) | Cellular receptor for HIV-1 VPR essential for G2/M phase transition of the cell cycle | |
US20120178163A1 (en) | Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same | |
KR20090087514A (ko) | 가용성 ctla4 돌연변이체 분자를 사용한 심혈관 질환의 치료 방법 | |
SK3532000A3 (en) | Dna sequence coding for kay ligand, method for the preparation of kay ligand, pharmaceutical composition containing said ligand and the use thereof | |
CA2911863A1 (fr) | Methodes et compositions destinees a traiter le cancer | |
CN101389651A (zh) | 受体特异性肿瘤坏死因子相关的细胞凋亡诱导配体(trail)的突变体 | |
TW202102542A (zh) | 用於治療癌症的聯合療法 | |
JP2001502538A (ja) | ミニe1a遺伝子及び遺伝子産物 | |
US6448078B1 (en) | Cellular receptor for HIV-1 Vpr essential for G2/M phase transition of the cell cycle | |
US6218363B1 (en) | MHC peptides and methods of use | |
Fischer et al. | Cutting-edge apoptosis-based therapeutics: a panacea for cancer? | |
JP2005500247A (ja) | ヒトmda−7に関わる処置方法 | |
Li et al. | Mechanism of action differences in the antitumor effects of transmembrane and secretory tumor necrosis factor-alpha in vitro and in vivo | |
AU770157B2 (en) | Use of semaphorin for modulation of cellular efflux | |
US6191269B1 (en) | Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide | |
JP2011102322A (ja) | 毒性が低下したtnfファミリーのリガンド、リガンドのアゴニストの投与方法 | |
WO2001017559A9 (fr) | Modulation par semaphorines de la migration des cellules immunitaires | |
US7176179B1 (en) | Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide | |
WO2001052883A1 (fr) | Inhibiteurs du recepteur-2 active par une protease (par-2) utilises comme nouveaux agents therapeutiques contre l'asthme | |
WO2023049921A1 (fr) | Peptide inhibiteur de pd-l1 pour l'immunothérapie anticancéreuse | |
WO2022056493A1 (fr) | Procédés pilotés par des biomarqueurs pour le traitement d'un trouble dépressif majeur | |
JP2006524712A (ja) | カテプシンの阻害のための方法および組成物 | |
JP2023524558A (ja) | Pcna相互作用モチーフを含むペプチドの固形癌の治療における使用 | |
AU767967B2 (en) | Modulators of TNF receptor associated factor (TRAF), their preparation and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |